Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma characterized by distinct subtypes and heterogeneous treatment outcomes. Oxidative stress and the dysregulation of related regulatory genes are prevalent in DLBCL, prompting an investigation into the nuclear factor erythroid 2-re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncology letters 2025-01, Vol.29 (1), p.30, Article 30
Hauptverfasser:	Hsu, Chin-Mu, Kao, Shih-Yu, Yen, Chia-Hung, Hsiao, Chi-En, Cho, Shih-Feng, Wang, Hui-Ching, Yeh, Tsung-Jang, Du, Jeng-Shiun, Wang, Min-Hong, Hsieh, Tzu-Yu, Hsiao, Samuel Yien, Tsai, Yuhsin, Hung, Li-Chuan, Liu, Yi-Chang, Chang, Kung-Chao, Hsiao, Hui-Hua
Format:	Artikel
Sprache:	eng
Schlagworte:	Antioxidants Automation Autophagy Biomarkers Cancer Gene expression Genomes Lymphoma Medical prognosis Oxidative stress Polymers Software
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!